Disc Medicine IRON
NASDAQ IRON
$79.49 +0.12 (+0.15%)
As of: Sep 4, 2026 · 3:13 PM EDT

Disc Medicine (IRON) Total Liabilities (2020 - 2026)

Disc Medicine (IRON) posted quarterly Total Liabilities of $90.9 million for Q2 2026, up 78.61% year-over-year from $50.9 million in Q2 2025, and up 47.14% quarter-over-quarter from $61.8 million in Q1 2026.

Analysis

Disc Medicine (IRON) Total Liabilities (2020 - 2026) Analysis & Trends

Disc Medicine (IRON) has reported Total Liabilities for 7 consecutive years, with $90.9 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Total Liabilities rose 78.61% year-over-year to $90.9 million; the TTM figure through Jun 2026 stood at $90.9 million (up 78.61% YoY), while the FY2025 annual figure was $67.1 million, up 26.07% from the prior year.
  • Total Liabilities climbed to $90.9 million in Q2 2026 per IRON's latest filing, from $61.8 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $90.9 million in Q2 2026 and bottomed at $1.5 million in Q3 2022.
  • Historically, Total Liabilities has averaged $33.5 million across 5 years, with a median of $23.2 million in 2022.
  • Annual changes were most pronounced in 2022 — Total Liabilities tumbled 90.02% — and 2023, when it jumped 1096.93%.
  • Disc Medicine's Total Liabilities stood at $23.6 million in 2022, then retreated by 3.09% to $22.9 million in 2023, then soared by 132.51% to $53.2 million in 2024, then grew by 26.07% to $67.1 million in 2025, then surged by 35.57% to $90.9 million in 2026.
  • Business Quant data shows IRON's Total Liabilities at $90.9 million in Q2 2026, $61.8 million in Q1 2026, and $67.1 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 1.62 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 4.20 Bn
5 Revolution Medicines 44.02 Bn 44.02 Bn - 1.72 Bn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 4.00 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 4.20 Bn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 10.03 Bn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.35 Bn
10 Disc Medicine 3.08 Bn 3.08 Bn - 90.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 90.91 Mn
Mar 31, 2026 61.78 Mn
Dec 31, 2025 67.05 Mn
Sep 30, 2025 57.07 Mn
Jun 30, 2025 50.90 Mn
Mar 31, 2025 48.90 Mn
Dec 31, 2024 53.19 Mn
Sep 30, 2024 27.19 Mn
Jun 30, 2024 21.39 Mn
Mar 31, 2024 16.11 Mn
Dec 31, 2023 22.88 Mn
Sep 30, 2023 17.52 Mn
Jun 30, 2023 12.96 Mn
Mar 31, 2023 10.93 Mn
Dec 31, 2022 23.61 Mn
Sep 30, 2022 1.46 Mn
Jun 30, 2022 6.44 Mn
Mar 31, 2022 12.67 Mn
Dec 31, 2021 14.76 Mn
Sep 30, 2021 14.67 Mn